Stay updated on ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference13%

- Check34 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software release.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top link has been removed.SummaryDifference0.8%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.8%

- Check63 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference8%

- Check77 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.